Opposition 91297389
OtherUSPTO
Opposition 91297389 at USPTO between Sanofi Biotechnology and Xiromed Pharma Espana, S.L., over the mark LEBERTY, filed Mar 4, 2025. Status in the office record: other.
- Status
- Other
- Result
- Other
- Filed
- Mar 4, 2025
- Marks involved
- 2
Parties
Who is involved
The parties as named in the office record.
Respondent
Xiromed Pharma Espana, S.L.
Timeline
How the case has moved
Dates from the USPTO record and the LEBERTY filing.
LEBERTY filed
Application 98456707 filed at the USPTO.Opposition filed
Sanofi Biotechnology started opposition 91297389 at USPTO against LEBERTY.
Marks
Marks involved
1 contested mark, 1 mark the challenger relies on.
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_bfedeaae-d5a4-436a-9f79-b3bf51fa086b
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_bfedeaae-d5a4-436a-9f79-b3bf51fa086b",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91297389",
"status": "other",
"office_code": "US",
"filed_date": "2025-03-04",
"parties": [
{
"name": "Sanofi Biotechnology",
"role": "opponent"
},
{
"name": "Xiromed Pharma Espana, S.L.",
"role": "respondent"
}
]
}